Panel sees promise in Novartis' cancer drug - Bizjournals.com


Wall Street Journal
Panel sees promise in Novartis' cancer drug
Bizjournals.com -10 hours ago
Novartis AG said Thursday that an independent data monitoring committee stopped a major trial of an investigational drug after interim results showed significantly better survival rates in kidney-cancer patients taking the therapy.
UPDATE 1-Novartis kidney cancer drug clears key hurdleReuters
Novartis Drug Shows Promise for Kidney CancerWall Street Journal
CNNMoney.com - MarketWatch - MedPage Today - Trading Markets (press release)
all 32 news articles

More: continued here

Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
  • BlinkList
  • blogmarks
  • co.mments
  • del.icio.us
  • De.lirio.us
  • digg
  • Furl
  • Ma.gnolia
  • NewsVine
  • Reddit
  • Shadows
  • Simpy
  • Smarking
  • Spurl
  • YahooMyWeb



   Posted in Health News    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.





No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment